107 related articles for article (PubMed ID: 33535803)
1. Deep Brain Stimulation for OCD in a Patient With Comorbidities: Epilepsy, Tics, Autism, and Major Depressive Disorder.
Davis RA; Winston H; Gault JM; Kern DS; Mikulich-Gilbertson SK; Abosch A
J Neuropsychiatry Clin Neurosci; 2021; 33(2):167-171. PubMed ID: 33535803
[No Abstract] [Full Text] [Related]
2. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
3. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
McDougle CJ; Fleischmann RL; Epperson CN; Wasylink S; Leckman JF; Price LH
J Clin Psychiatry; 1995 Nov; 56(11):526-8. PubMed ID: 7592506
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.
Morinobu S; Yamashita H; Yamawaki S; Tanaka K; Ohkawa M
J Clin Psychiatry; 2002 Sep; 63(9):838-40. PubMed ID: 12363127
[No Abstract] [Full Text] [Related]
6. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Yoshimura R; Kaneko S; Shinkai K; Nakamura J
Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759
[TBL] [Abstract][Full Text] [Related]
7. Fourteen-Pound Fluvoxamine-Associated Weight Gain in a Young Woman with Depression and Multiple Anxiety Symptoms.
Jaffe RJ; Juneja NS; Juneja NS; Jaffe RJ; Coffey BJ
J Child Adolesc Psychopharmacol; 2018 Sep; 28(7):488-490. PubMed ID: 30226805
[No Abstract] [Full Text] [Related]
8. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
9. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report.
Chiou YJ; Lin PY; Lee Y
Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281
[TBL] [Abstract][Full Text] [Related]
10. Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA; Bullock T; Fineberg N
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
[No Abstract] [Full Text] [Related]
11. Staying Up at Night: Overlapping Bipolar and Obsessive-Compulsive Disorder Symptoms in an Adolescent with Autism Spectrum Disorder.
Cawkwell P; Lawler A; Maneta E; Coffey BJ
J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):74-7. PubMed ID: 26881860
[No Abstract] [Full Text] [Related]
12. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
Mundo E; Guglielmo E; Bellodi L
Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
[TBL] [Abstract][Full Text] [Related]
14. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
Schaller JL; Behar D; Chamberlain T
J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
[No Abstract] [Full Text] [Related]
15. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
[TBL] [Abstract][Full Text] [Related]
16. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report.
McDougle CJ; Price LH; Goodman WK
J Autism Dev Disord; 1990 Dec; 20(4):537-43. PubMed ID: 2126264
[TBL] [Abstract][Full Text] [Related]
17. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
Sevincok L; Uslu A; Kaynak H; Dereboy F
J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992
[No Abstract] [Full Text] [Related]
18. Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.
Tikka SK; Garg S; Das B
Indian J Pharmacol; 2013; 45(5):532-3. PubMed ID: 24130396
[TBL] [Abstract][Full Text] [Related]
19. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
Ravindran AV
J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
[No Abstract] [Full Text] [Related]
20. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
